Cf drug orkambi can be given to children following eu approval

The pharmaceutical firm making cystic fibrosis drug - Orkambi- says it's got EU approval to treat children.

Manufacturer Vertex says it'll now be suitable for use for those aged 6 to 11. It's already licensed for patients 12 and over. Earlier this year the HSE agreed to make Orkambi available to Irish patients after major price negotiations with the pharma industry.